Furthermore, the resistance or sensitivity of tumor cells to therapeutic agents may be associated with BiP/GRP78, a chaperone protein that binds to monomers downstream of the UPR and stabilizes IRE1, PERK, and ATF6. The gene discussed is ATF6; the disease is neoplasm.